Period Ending: |
LTM
(Last Twelve Months) |
2023 12-31 |
2022 12-31 |
2021 12-31 |
2020 12-31 |
2019 12-31 |
2018 12-31 |
2017 12-31 |
---|---|---|---|---|---|---|---|---|
Report Filing | 2024-04-30 | 2023-04-28 | 2022-04-29 | 2021-04-19 | 2020-04-29 | 2019-04-15 | 2017-12-31 | |
Revenue | 0.43 | 1.30 | 1.54 | 0.91 | 0.54 | 0.38 | 0.00 | |
Cost of Revenue | 1.55 | 1.22 | 1.46 | 1.02 | 0.79 | 0.32 | 0.06 | |
Gross Profit | -1.11 | 0.08 | 0.08 | -0.10 | -0.26 | 0.07 | -0.06 | |
Operating Expenses | 9.41 | 23.0 | 19.1 | 19.8 | 19.5 | 10.4 | 5.63 | |
Research & Development | 4.13 | 9.22 | 10.9 | 11.6 | 6.94 | 3.10 | 2.50 | |
Selling, General and Administrative | 4.41 | 7.97 | 7.80 | 7.71 | 10.8 | 6.73 | 2.88 | |
Other Operating Expenses | 0.87 | 5.86 | 0.48 | 0.48 | 1.75 | 0.56 | 0.26 | |
Operating Income | -10.5 | -23.0 | -19.1 | -19.9 | -19.7 | -10.3 | -5.69 | |
Net Non-Operating Interest | 0.00 | 0.00 | -0.09 | -0.24 | 3.70 | 4.46 | 0.04 | |
Interest Income | 0.00 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | |
Interest Expense | 0.00 | 0.15 | 0.09 | 0.24 | -3.70 | -4.46 | 0.00 | |
Equity & Other Income/(Expense) | 6.18 | 11.4 | -7.96 | 25.0 | -4.09 | -9.26 | 3.09 | |
Income Before Tax | -4.34 | -11.5 | -27.1 | 4.92 | -20.1 | -15.1 | -2.56 | |
Income Tax Expense | -1.52 | -6.21 | -1.83 | -1.51 | 0.74 | -0.30 | -0.01 | |
Income Attributable to Non-Controlling Interest | 0.00 | 0.00 | 0.00 | -0.64 | 0.00 | 0.00 | 0.00 | |
Net Income | -2.82 | -5.31 | -25.3 | 7.07 | -20.9 | -14.8 | -2.55 | |
Depreciation and Amortization | 1.13 | 1.21 | 1.19 | 1.33 | 1.30 | 0.68 | 0.06 | |
EBITDA | -9.40 | -21.8 | -17.9 | -18.5 | -18.4 | -9.65 | -5.63 | |
Earnings Per Share (EPS) | -0.620 | -14.89 | -7.220 | 2.030 | -7.190 | -5.310 | -0.850 | |
Diluted Earnings Per Share | -0.620 | -14.89 | -7.220 | 2.000 | -7.190 | -5.310 | -0.850 | |
Weighted Average Shares Outstanding | 4.52 | 0.36 | 3.50 | 3.11 | 2.90 | 2.79 | 3.01 | |
Diluted Weighted Average Shares Outstanding | 4.52 | 0.36 | 3.50 | 3.15 | 2.90 | 2.79 | 3.01 |